ESR1 and breast cancer: In addition, incubation of luminal breast cancer cells exposed to hormonal therapy with miR-221-containing CAF-derived exosomes resulted in the activation of the ER/Notch feed-forward loop, the generation of CD133 CSCs with low expression levels of estrogen receptor alpha, and consequently, the development of de novo hormonal therapy resistance [165].